Diversified Healthcare: Q3 Earnings Snapshot

Diversified Healthcare Trust (DHC) reported Q3 funds from operations of $30.7M, or 13 cents per share, and a net loss of $50.2M, or 21 cents per share. Revenue was $367.7M. The company expects full-year funds from operations between 46-52 cents per share.

Original reporting
Published Nov 3, 2026, 4:28 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 4:39 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Diversified Healthcare: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$DHCBearishMed
01

Why it matters

The Q3 earnings miss and modest guidance suggest short‑term weakness, but the stable FFO yield may attract income‑focused investors.

02

Market read

New earnings data provides a fresh catalyst for DHC traders; the guidance range sets expectations for the remainder of the year.

03

What to watch

Potential upside from upcoming Medicare policy changes that could boost occupancy in senior‑care facilities.

Relevance 7/10Novelty 8/10Timing: today

Background

Diversified Healthcare Trust (DHC) is a publicly traded REIT focused on senior‑care and residential health facilities.

Company-level read

Ticker impact

$DHCBearishHigh confidence
Context

Diversified Healthcare Trust reported Q3 funds from operations of $30.7M (13c/share) and a loss of $50.2M, plus guidance of 46‑52c FFO for the year.

Expected impact

likely downside as the market prices in the loss and modest guidance

Evidence & confidence

The REIT posted a loss and guidance that is modest relative to prior expectations, which typically triggers a sell‑off in the short term.

Market effects

The REIT sector may see slight pressure as investors reassess Q3 performance across healthcare real estate.

US REIT market may experience modest pullback in the afternoon trading session.

Limited to US-listed REIT investors; no broader global impact.

Counterpoint

If investors view the loss as a one‑off and focus on the stable FFO yield, the stock could be a buying opportunity.

Key entities

  • Diversified Healthcare Trust

    US‑listed REIT specializing in senior‑care real estate.

Related articles

$DHCMedAI 8/10

Diversified Healthcare Trust (DHC) Q3 2026 Earnings Call Highlights: SHOP NOI Surges 50%

Diversified Healthcare Trust (DHC) reported Q3 2026 earnings, raising same-property SHOP NOI guidance by $5M. SHOP NOI surged 50.4% YoY to $48M, driven by occupancy gains and rate growth. DHC reduced 2026 recurring CapEx guidance by $10M. Normalized FFO guidance was lowered due to incentive management fees. Medical office and life science NOI declined 1.6% YoY. DHC's leverage is 8.2x, above its target range. The company expects further CapEx reductions and improved balance sheet metrics.

$DHCMedAI 8/10

DHC (DHC) Q3 2026 Earnings Call Transcript

DHC reported Q3 2026 normalized FFO of $30.7M ($0.13/share) and Adjusted EBITDAre of $73.4M, up 28.4% YoY. Same-property NOI rose 25.6% to $77.9M. The company raised guidance for same-property NOI and reduced expected capital expenditures. DHC also announced portfolio optimizations, including a 15-year triple net lease for 7 Colorado nursing facilities and management transitions for 6 communities in Georgia. The company is pursuing property sales to eliminate negative NOI and reinvest capital.

$DHCMedAI 8/10

Diversified Healthcare Trust Q3 Earnings Call Highlights

Diversified Healthcare Trust (DHC) reported Q3 earnings, with its senior housing operating portfolio (SHOP) driving improvements. Same-property SHOP NOI rose 50.4% YoY to $48M, and occupancy increased to 84.4%. The company raised 2026 SHOP NOI guidance by $5M at the midpoint. DHC also announced lease and management changes, and plans for portfolio conversions and dispositions.

$DHCMedAI 8/10

DHC Q3 2026 slides: SHOP segment surges 50% despite earnings miss

Diversified Healthcare Trust (DHC) reported Q3 2026 results with a net loss of $0.21 per share, missing estimates. Shares fell 2.58% to $7.54. The SHOP segment saw a 50.4% NOI increase, while medical office and life science faced challenges. DHC raised same-property NOI guidance but lowered EBITDAre and FFO guidance due to management fees. The company has $260.7M in liquidity and a debt-to-EBITDAre ratio of 8.2x.